Tag:
Quad
Latest Headlines
Latest Headlines
FDA panel OKs Gilead's key HIV drug Quad
The four-in-one pill for HIV won support from an FDA advisory committee Friday, bolstering the Foster City, CA-based company's efforts to gain approval of the drug and maintain its top position in the market for HIV and AIDS drugs.
FDA advisory panel backs Truvada for HIV prevention
It is two down and one to go for Truvada, the Gilead Sciences ($GLD) HIV medication. An FDA advisory panel, following the lead of the agency staff, recommended 19-3 that the drug be prescribed to people at high risk as a preventive against HIV infection.
FDA details kidney damage in Gilead's Quad studies
The kidney damage could warrant monitoring of patients taking the drug, the FDA staff briefing said, according to Bloomberg .
Advisory panels take up Gilead's Truvada, then Quad
It will be up to an advisory panel to say whether Truvada's potential is undercut by the chance patients won't take it or that drug resistance is too likely.
Gilead spotlights key details from pivotal Quad study
Gilead Sciences ( $GILD ) has unveiled important details from a pivotal study for its Quad pill for HIV, showing the industry that the four-drug combo was as effective as its approved Atripla med...
Gilead asks FDA to approve blockbuster hopeful Quad against HIV
Gilead has taken another step forward with its HIV treatment known as Quad. The company ( $GILD ) revealed yesterday that it has filed for FDA approval of the potential blockbuster, a four-drug combo
Gilead accelerates app schedule after Quad aces comparison study
Gilead ( $GILD ) has said its blockbuster HIV hopeful Quad edged out a rival treatment in a non-inferiority study, encouraging the developer to accelerate its schedule for a marketing application and
Gilead faces high hopes for "Quad" as it hatches big expansion plan
Gilead ( $GILD ) will have to clear a high hurdle for its new HIV treatment to meet analysts' expectations. After leaving investors a bit deflated by its first set of pivotal data last month--which
